Latest

22:09
[ XIMEI RESOURCES (09936.HK): Expected H1 Profit Attributable to Shareholders of RMB163.9 Million to RMB200.3 Million ] NewTimeSpace News: XIMEI RESOURCES announced on 12 August that profit attributable to shareholders for the six-month period ending 30 June 2026 is expected to be approximately RMB163.9 million to RMB200.3 million, a notable increase from around RMB91.8 million in the corresponding period last year.
Tag： XIMEI RESOURCES09936.HK
22:04
[ China Aluminum Cans (06898.HK): H1 Net Profit Expected to Rise Over 30% Year-on-Year ] NewTimeSpace News: China Aluminum Cans announced on 12 August that net profit attributable to equity holders of the Company for the six-month period ending 30 June 2026 is expected to increase by more than 30% compared with the same period last year.
Tag： China Aluminum Cans06898.HK
22:00
[ CSPC Pharmaceutical Group (01093.HK): Receives US$30 Million Upfront Payment Under siRNA Collaboration Agreement with AstraZeneca ] NewTimeSpace News: CSPC Pharmaceutical Group announced on 12 August that pursuant to the collaboration, option and licence agreement with AstraZeneca for siRNA drug development, the Group received the US$30 million upfront payment from AstraZeneca on 12 August 2026.
Tag： CSPC Pharmaceutical Group01093.HK
21:55
[ New City Development Group (00456.HK): Appointment of Li Yang as Co-Chief Executive Officer ] NewTimeSpace News: New City Development Group announced on 12 August that Li Yang has been appointed Co-Chief Executive Officer of the Company, and Han Junran has been re-designated from Chief Executive Officer to Co-Chief Executive Officer, with effect from 12 August 2026.
Tag： New City Development Group00456.HK
20:06
[ ORIENTAL EXPL (00430.HK): Expects Interim Profit to Fall to Approximately HK$ 3,000,000-3,200,000 on Lower Rental Income ] NewTimeSpace News: On 12 August 2026, Oriental Explorer Holdings Limited(00430.HK) issued a profit warning. Consolidated profit attributable to shareholders for the interim period is expected to decline to approximately HK$3,000,000 to HK$3,200,000 (compared with around HK$4,300,000 in the corresponding period of 2025), mainly due to lower rental income from commercial and industrial properties. Nevertheless, the Group’s overall financial position remains sound.
Tag： ORIENTAL EXPL00430.HKProfit Warning
20:00
[ V.S. INT'L (01002.HK): Expects Interim Profit of USD 3,000,000-4,000,000, Markedly Up from the Same Period Last Year ] NewTimeSpace News: On 12 August 2026, V.S. INT'L (01002.HK) issued a positive profit warning, expecting an interim profit of USD 3,000,000-4,000,000 (versus approximately USD 900,000 in the same period of 2025) and a profit attributable to owners of USD 2,000,000-3,000,000, mainly due to business expansion, higher rental income and lower selling expenses.
Tag： V.S. INTL01002.HKProfit Alert
19:33
[ HENGRUI PHARMA (01276.HK): SHR-7590 Injection Receives Drug Clinical Trial Approval Notice for Ulcerative Colitis and Crohn's Disease ] NewTimeSpace News: On 12 August 2026, HENGRUI PHARMA (01276.HK) disclosed that its subsidiary Guangdong Hengrui received the Drug Clinical Trial Approval Notice for SHR-7590 Injection, approving clinical trials for ulcerative colitis and Crohn's disease; the drug is an in-house developed therapeutic biologic with no same-target drug approved globally, and cumulative R&D investment of approximately RMB 32.5 million.
Tag： HENGRUI PHARMA01276.HKR&D Progress
19:31
[ CAPINFO (01075.HK): Expects Interim Results to Swing to Loss of Approximately RMB 30-50 Million ] NewTimeSpace News: On 12 August 2026, CAPINFO (01075.HK) issued a profit warning, expecting an interim loss attributable to equity shareholders of approximately RMB 30-50 million, swinging from a profit of RMB 9.54 million in the same period of 2025, mainly due to higher fulfillment costs, increased R&D investment and the one-off impact of a RMB 52.79 million liquidation gain recognized last year.
Tag： CAPINFO01075.HKProfit Warning
19:28
[ CH TIANBAO GP (01427.HK): Expects Interim Net Loss to Widen to RMB 60-70 Million on Reduced Revenue ] NewTimeSpace News: On 12 August 2026, CH TIANBAO GP (01427.HK) issued a profit warning, expecting its interim net loss to widen to RMB 60.0-70.0 million from RMB 37.3 million in the same period of 2025, mainly due to reduced revenue from fewer construction contracts following proactive control of undertaking scale and lower average selling prices of buildings.
Tag： CH TIANBAO GP01427.HKProfit Warning
19:19
[ MULTIFIELD INTL (00898.HK): Expects Interim Profit to Fall to Approximately HK$ 100-120 Million on Lower Fair Value Gains on Financial Assets ] NewTimeSpace News: On 12 August 2026, MULTIFIELD INTL (00898.HK) issued a profit warning. Consolidated profit attributable to shareholders for the interim period is expected to range from approximately HK$100 million to HK$120 million (versus around HK$238 million in the corresponding period of 2025). The decline is mainly driven by a drop in net fair value gains on financial assets at fair value through profit or loss from roughly HK$208 million to about HK$46 million, representing a non-cash movement.
Tag： MULTIFIELD INTL00898.HKProfit Warning
19:12
[ HENGRUI PHARMA (01276.HK): HRS-4729 Injection Approved for Phase II Clinical Trial in Type 2 Diabetes ] NewTimeSpace News: On 12 August 2026, HENGRUI PHARMA (01276.HK) disclosed that HRS-4729 Injection, an in-house developed GLP-1R/GIPR/GCGR tri-agonist polypeptide, received NMPA approval for a Phase II clinical trial in adult type 2 diabetes patients, with a Phase II trial for weight loss also being advanced, and cumulative R&D investment of approximately RMB 81.6 million.
Tag： HENGRUI PHARMA01276.HKR&D Progress
19:07
[ CHUANGLIAN HOLD (02371.HK): Zhang Jie Resigns as Executive Director, Gao Rui Appointed to Replace Him, Effective 12 August 2026 ] NewTimeSpace News: On 12 August 2026, CHUANGLIAN HOLD (02371.HK) announced that Mr. Zhang Jie resigned as executive director effective 12 August 2026 and will remain a senior management member, and Ms. Gao Rui was appointed as executive director on the same date with a fixed one-year term and a monthly salary of RMB 30,000.
Tag： CHUANGLIAN HOLD02371.HKBoard Change
19:00
[ DREAM INT'L (01126.HK): Expects Interim Net Profit to Decrease by 25%-35% on Higher Labor and Raw Material Costs ] NewTimeSpace News: On 12 August 2026, DREAM INT'L (01126.HK) issued a profit warning, expecting its net profit for the six months ended 30 June 2026 to decrease by approximately 25% to 35% compared with the same period in 2025, mainly due to increased labor costs and higher raw material prices.
Tag： DREAM INTL01126.HKProfit Warning
18:56
[ HERBS GROUP (02593.HK): Expects Interim Net Loss to Narrow by 40%-53% on Lower Advertising and Promotion Expenses ] NewTimeSpace News: On 12 August 2026, Herb Standard Group (02593.HK) released a profit forecast. The interim net loss is expected to narrow to approximately HK$3.5 million to HK$4.5 million (compared with around HK$7.5 million in the same period of 2025), representing a reduction of roughly 40% to 53%. The improvement is mainly attributable to lower advertising and promotion expenses, which is partially offset by declines in revenue and gross profit resulting from weaker sales in the retail business.
Tag： HERBS GROUP02593.HKNet Loss Narrow
18:48
[ TH MEDICAL-B (02697.HK): Wins Bidding for Yunnan Agricultural University Research Equipment Project, Deal Value RMB 2.8 Million ] NewTimeSpace News: On 12 August 2026, TH MEDICAL-B (02697.HK) announced that it was confirmed as the winning supplier for a research equipment procurement project of Yunnan Agricultural University (Project No.: YNGH[2026]-0626), covering one set of multi-organ multi-sensor normothermic perfusion system with built-in ventilator, with a total transaction amount of RMB 2.8 million.
Tag： TH MEDICAL-B02697.HKBid Award
18:43
[ ACOTEC-B (06669.HK): Expects Interim Results to Swing to Net Loss of up to RMB 80.9 Million on Termination of U.S. Clinical Project ] NewTimeSpace News: On 12 August 2026, ACOTEC-B (06669.HK) issued a profit warning, expecting a net loss of not more than RMB 80.9 million for the six months ended 30 June 2026, versus a net profit of approximately RMB 88.6 million in the same period of 2025, mainly due to the termination of the U.S. clinical project for the AcoArt Litos paclitaxel-coated PTA balloon catheter, which triggered one-off impairment and expense provisions totaling approximately RMB 150.8 million.
Tag： ACOTEC-B06669.HKProfit Warning
18:39
[ ASIASEC PPT (00271.HK): Expects Interim Net Loss to Widen to Approximately HK$ 110-120 Million on Lower Investment Property Fair Value ] NewTimeSpace News: On 12 August 2026, Asia Properties & Finance (00271.HK) issued a profit warning. The Group expects the net loss for the six-month period ending 30 June 2026 to range from approximately HK$110 million to HK$120 million, widening from around HK$63 million in the corresponding period of 2025, mainly due to a larger fair value reduction of investment properties.
Tag： ASIASEC PPT00271.HKProfit Warning
18:30
[ NEW SILKROAD (00472.HK): Expects Interim Net Loss to Narrow to Approximately HK 13.9 M i l l i o n t o H K 13.9MilliontoHK 17.0 Million, Mainly on Reduced Goodwill Impairment ] NewTimeSpace News: On 12 August 2026, New Silk Road Holdings Group (00472.HK) released a profit forecast. The Group expects its net loss for the six-month period ending 30 June 2026 to narrow to approximately HK$13.9 million to HK$17.0 million, compared with around HK$41.7 million recorded in the same period of 2025, mainly due to lower impairment loss on goodwill.
Tag： NEW SILKROAD00472.HKNet Loss Reduction
18:23
[ BQD (03866.HK): Regulatory Approval for Zhang Shixing's Independent Non-Executive Director Qualification, Effective 10 August 2026 ] NewTimeSpace News: On 12 August 2026, BQD (03866.HK) announced that the Qingdao Regulatory Bureau of the National Financial Regulatory Administration approved Mr. Zhang Shixing's qualification as an independent non-executive director of the Bank (Qing Jin Fu [2026] No. 158); he assumed office from 10 August 2026, while Mr. Fan Xuejun ceased to hold the relevant positions.
Tag： BQD03866.HKBoard Change
18:17
[ OSL GROUP (00863.HK): Wong Koon Man Appointed as Executive Director, Effective 12 August 2026 ] NewTimeSpace News: On 12 August 2026, OSL GROUP (00863.HK) announced the appointment of Mr. Wong Koon Man as executive director with effect from 12 August 2026.
Tag： OSL Group Limited00863.HKBoard Change
Previous1..177178 179180181..576     576 pages total
×
Share to WeChat

Open WeChat, use "Scan," and share to my Moments